Hikma pharmaceuticals shares
WebFeb 23, 2024 · (RTTNews) - Shares of Hikma Pharmaceuticals PLC (HIK, HIK.L) were gaining around 4 percent in the early morning trading in London after the company on Thursday said it is confident of fiscal 2024 ... WebApr 12, 2024 · Hikma Pharmaceuticals - HKMPY Stock Forecast, Price & News $41.31 0.00 (0.00%) (As of 03/20/2024 12:00 AM ET) Compare Today's Range $41.31 $41.31 50-Day Range $40.43 $43.77 52-Week Range $25.12 $58.01 Volume 182 shs Average Volume 1,788 shs Market Capitalization N/A P/E Ratio 13.35 Dividend Yield 0.77% Price Target N/A …
Hikma pharmaceuticals shares
Did you know?
WebIn June 2024, Boehringer announced it would sell off part of its stake in London-listed Hikma Pharmaceuticals (28 million out of a 40 million share holding) for around $800 million. … WebApr 12, 2024 · Shares of Hikma Pharmaceuticals PLC ( LON:HIK – Get Rating) crossed above its two hundred day moving average during trading on Tuesday . The stock has a …
WebMar 15, 2024 · Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate May 21. Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly May 03. Hikma Pharmaceuticals PLC Announces US FDA Approval of KLOXXADO Apr 30. WebTotal shares owned by institutions decreased in the last three months by 5.13% to 23,406K shares. See all Hikma Pharmaceuticals regulatory filings . This story originally appeared on Fintel .
WebFeb 21, 2024 · Hikma Pharmaceuticals' estimated fair value is UK£21.03 based on 2 Stage Free Cash Flow to Equity With UK£17.69 share price, Hikma Pharmaceuticals appears to be trading close to its estimated fair value Our fair value estimate is 8.3% lower than Hikma Pharmaceuticals' analyst price target of US$19.28 WebApr 13, 2024 · Hikma Pharmaceuticals Stock Up 1.6 %. Shares of HIK opened at GBX 1,804.50 ($22.35) on Wednesday. The firm has a market cap of £3.98 billion, a P/E ratio of …
WebHikma pharmaceuticals share price is set and traded on the London Stock Exchange (LSE) under the ticker symbol HIK. The company constitutes the FTSE 100 and FTSE 350 …
WebTotal shares owned by institutions decreased in the last three months by 5.13% to 23,406K shares. See all Hikma Pharmaceuticals regulatory filings . This story originally appeared … floth real estateWebApr 14, 2024 · In other Hikma Pharmaceuticals news, insider Deneen Vojta purchased 1,000 shares of the firm’s stock in a transaction on Tuesday, January 17th. The shares were purchased at an average price of GBX 1,703 ($21.09) per share, for a total transaction of £17,030 ($21,089.78). Corporate insiders own 29.57% of the company’s stock. floth real estate gmbhWebJan 18, 2024 · Vojta, who joined Hikma in October 2024, purchased the shares on Tuesday at an average price of 1,702.68p each, for a total value of £17,026.76. Earlier in January, Hikma Pharmaceuticals launched ... floth pressathWebHIKMA PHARMACEUTICALS PLC HIK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals greedy colouring algorithmWeb*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; greedy coloring of bipartite graphsWebHIKMA PHARMACEUTICALS (HIK) Shares ABOUT HIKMA PHARMACEUTICALS. Hikma Pharmaceuticals, a multinational pharmaceutical company, was founded in 1978 and is headquartered in London in the United Kingdom.The company manufactures non-branded generic and in-licensed pharmaceutical products. greedy coloring proofWebApr 14, 2024 · 6 brokers have issued 12-month price targets for Hikma Pharmaceuticals' stock. Their HIK share price forecasts range from GBX 1,700 to GBX 2,100. On average, … flothroo